TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction (DoPING-HFpEF): Rationale and design of a placebo-controlled cross-over intervention study.

被引：0
|
作者：
Van De Bovenkamp, A. A. [1 ]
Bakermans, A. J. [2 ]
Allaart, C. P. [1 ]
Nederveen, A. J. [2 ]
Kok, W. E. M. [3 ]
Van Rossum, A. C. [1 ]
Handoko, M. L. [1 ]
机构：
[1] Amsterdam UMC, Locat VUmc, Cardiol, Amsterdam, Netherlands
[2] Amsterdam UMC, Locat Acad Med Ctr, Radiol & Nucl Med, Amsterdam, Netherlands
[3] Amsterdam UMC, Locat Acad Med Ctr, Clin & Expt Cardiol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2022
引用
收藏
页码：357 / 357
页数：1
相关论文
共 36 条
  • [31] Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials
    Tomas Vetrovsky
    Michal Siranec
    Jiri Parenica
    Martin Griva
    Jiri Stastny
    Jan Precek
    Radek Pelouch
    Vaclav Bunc
    Ales Linhart
    Jan Belohlavek
    Journal of Translational Medicine, 15
  • [32] Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trials
    Vetrovsky, Tomas
    Siranec, Michal
    Parenica, Jiri
    Griva, Martin
    Stastny, Jiri
    Precek, Jan
    Pelouch, Radek
    Bunc, Vaclav
    Linhart, Ales
    Belohlavek, Jan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [33] Effect of ursodeoxycholic acid on peripheral blood flow, immune function & markers of neurohormonal activation in chronic heart failure: a randomised, placebo-controlled, double-blind cross-over study
    Von Haehling, S.
    Jankowska, E. A.
    Vazir, A.
    Kalra, P. R.
    Sandek, A.
    Doehner, W.
    Volk, H. D.
    Poole-Wilson, P. A.
    Anker, S. D.
    EUROPEAN HEART JOURNAL, 2008, 29 : 305 - 305
  • [34] Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)
    Palau, Patricia
    Seller, Julia
    Dominguez, Eloy
    Gomez, Ines
    Maria Ramon, Jose
    Sastre, Clara
    de la Espriella, Rafael
    Santas, Enrique
    Minana, Gema
    Chorro, Francisco J.
    Ramon Gonzalez-Juanatey, Jose
    Nunez, Julio
    CLINICAL CARDIOLOGY, 2020, 43 (05) : 423 - 429
  • [35] Beneficial effects of a phosphodiesterase type 5 inhibitor (sildenafil) on exercise, neurohormonal activation, and erectile dysfunction in patients with congestive heart failure-α double-blind placebo-controlled cross-over ramdomized study
    Bocchi, EA
    Guimarâes, G
    Bellotti, G
    Ramires, JAF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 163A - 163A
  • [36] Effects of a phosphodiesterase type 5 inhibitor (sildenafil) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results
    Guimaraes, G. V.
    d'Avila, V. M.
    Pires, P. V.
    Cruz, F. D.
    Stolf, N. A.
    Chizzola, P. R.
    Bocchi, E. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S115 - S115
1234